These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6789673)
1. Von Willebrand disease associated with familial thrombocytopenia and increased ristocetin-induced platelet aggregation. Takahashi H; Nagayama R; Hattori A; Ihzumi T; Tsukada T; Shibata A Am J Hematol; 1981; 10(1):89-99. PubMed ID: 6789673 [TBL] [Abstract][Full Text] [Related]
2. Von Willebrand disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein. Takahashi H; Sakuragawa N; Shibata A Am J Hematol; 1980; 8(3):299-308. PubMed ID: 6774612 [TBL] [Abstract][Full Text] [Related]
3. Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation. Saba HI; Saba SR; Dent J; Ruggeri ZM; Zimmerman TS Blood; 1985 Aug; 66(2):282-6. PubMed ID: 3926021 [TBL] [Abstract][Full Text] [Related]
4. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation. Kinoshita S; Yoshioka K; Kasahara M; Takamiya O Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773 [TBL] [Abstract][Full Text] [Related]
5. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation. Niiya K; Kubonishi I; Taguchi H; Miyoshi I Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases. Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911 [TBL] [Abstract][Full Text] [Related]
7. Effect of a factor VIII concentrate on type IIB von Willebrand's disease-associated thrombocytopenia presenting during pregnancy in identical twin mothers. Ieko M; Sakurama S; Sagawa A; Yoshikawa M; Satoh M; Yasukouchi T; Nakagawa S Am J Hematol; 1990 Sep; 35(1):26-31. PubMed ID: 2117853 [TBL] [Abstract][Full Text] [Related]
8. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469 [TBL] [Abstract][Full Text] [Related]
10. Replacement therapy in platelet-type von Willebrand disease. Takahashi H Am J Hematol; 1985 Apr; 18(4):351-62. PubMed ID: 3919572 [TBL] [Abstract][Full Text] [Related]
11. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease. Barbui T; Dini E Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074 [TBL] [Abstract][Full Text] [Related]
12. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease. Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054 [TBL] [Abstract][Full Text] [Related]
13. Von Willebrand's disease with thrombocytopenia, platelet function defect, and an abnormal Factor VIII molecule. Arkel YS; Desposito F Am J Pediatr Hematol Oncol; 1982; 4(3):249-57. PubMed ID: 6816083 [TBL] [Abstract][Full Text] [Related]
14. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
15. Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity. Federici AB; Mannucci PM; Lombardi R; Lattuada A; Colibretti ML; Dent JA; Zimmerman TS Am J Hematol; 1989 Dec; 32(4):287-93. PubMed ID: 2510503 [TBL] [Abstract][Full Text] [Related]
16. Type IIB von Willebrand's disease associated with a complex thrombocytopenic thrombocytopathy. López-Fernández MF; López-Berges C; Martín-Bernal JA; Sánchez R; Villarón LG; Díez-Jarilla J; Batlle J Am J Hematol; 1988 Apr; 27(4):291-8. PubMed ID: 3258474 [TBL] [Abstract][Full Text] [Related]
18. The von Willebrand syndrome. Stableforth P; Hughes J; Wilson E; Dormandy KM Br J Haematol; 1975 Apr; 29(4):605-16. PubMed ID: 1081404 [TBL] [Abstract][Full Text] [Related]
19. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)]. Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131 [No Abstract] [Full Text] [Related]
20. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets. Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]